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Summary.-Equimolar doses of 7-methylbenz(a)anthracene and 3 of its derivatives
were given to newborn male and female Swiss mice. All 4 substances tested
increased the risk of tumour development compared with that seen in control mice
given the vehicle, arachis oil, only.
7-Methylbenz(a)anthracene itself was the most actively tumorigenic of the
compounds studied, giving rise to subcutaneous sarcomata at the site ofinjection, and
multiple lung tumours and liver tumours. 7-Bromomethyl-12-methylbenz(a)-
anthracene was similarly active in the lung and liver but evoked fewer subcutaneous
sarcomata. 7-Bromomethylbenz(a)anthracene was seemingly slightly less active
than either 7-methylbenz(a)anthracene or 7-bromomethyl-12-methylbenz(a)anthra-
cene. 4-Chloro-7-bromomethylbenz(a)anthracene exhibited only marginal activity
in that it slightly increased the risk of liver tumour development in male mice.
THE relation between structure and
carcinogenic activity of a series of 7-
bromomethylbenz(a)anthracenes has pre-
viously been investigated by the use of
test systems in which the incidence of
tumours at the site of a single application
of the agent is the measure of activity.
The use of such systems minimizes the
risk of interference by factors such as
peculiarities in transport of an agent to
a distant target tissue (Dipple and Slade,
1970, 1971). Whilst these studies allowed
the series of 7-bromomethylbenz(a)anthra-
cenes to be arranged in order of carcino-
genic potency, they did not provide a
convincing demonstration of the carcino-
genic activity of 7-bromomethylbenz(a)-
anthracene itself, which compound is the
most extensively studied member of this
series (for example, Dipple et al., 1971;
Michelson and Pochon, 1972 and refer-
ences therein; Daudel et al., 1971-72).
We have studied the development of
tumours after the administration of 7-
bromomethylbenz(a)anthracene to new-
born mice, a test system known to be
sensitive to a wide variety of chemical
carcinogens (Roe et al., 1971 and refer-
ences cited therein). The bromo-com-
pounds that were most active, and least
active in the previous tests, namely
7-bromomethyl- 12-methylbenz(a)anthra-
cene and 4-chloro-7-bromomethylbenz(a)-
anthracene respectively, together with the
parent hydrocarbon, 7-methylbenz(a)-
anthracene, were included in the present
study for comparison.
MATERIALS AND METHODS
Chemical agents.-7-Bromomethylbenz(a)-
anthracene, 7-bromomethyl-12-methylbenz-
(a)anthracene and 4-chloro-7-bromomethyl-
benz(a)anthracene were prepared as de-
scribed previously (Dipple and Slade, 1970,
1971). 7-Methylbenz(a)anthracene was
prepared by reduction of 7-bromomethyl-
benz(a)anthracene with stannous chloride/
HC1 (Wood and Fieser, 1940).
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Animal experiment8.-Litters from Swiss
female mice obtained from a pathogen-free
unit were grouped at random for treatment
so that each group would consist of 70-80
survivors at the time of weaning.
Mice were given a single subcutaneous
injection of test compound in 0-02 ml arachis
oil on each ofthe first 3 days oflife. Group A
received 7-methylbenz(a)anthracene (200 ,ug
per injection); Group B received 7-bromo-
methylbenz(a)anthracene (266 /.g per injec-
tion); Group C received 4-chloro-7-bromo-
methylbenz(a)anthracene (294 jig per injec-
tion); Group D received 7-bromomethyl-12-
methylbenz(a)anthracene (277 ,g per injec-
tion) and Group E received arachis oil only.
Thesedosesarethemolarequivalentsof200jig
of 7-methylbenz(a)anthracene.
Injections were made by introducing a
fine-gauge needle through the skin near the
root of the tail and threading it under the
skin to deliver the injected material in the
interscapular region.
After weaning at 3 weeks of age, males
and females were caged separately (in groups
of5) in metal boxes containing woodshavings.
The mice were fed on a standard diet (Formu-
lation 86 from Messrs C. Holdman and Son
(Plowco Feeds), Byers Lane, South Godstone,
Surrey) and water was given ad libitum.
Mice were examined daily as to their
general state of health, and more closely at
weekly intervals for palpable tumours and
other lesions. Mice with palpable tumours
and any that were sick were killed and
examinedcarefullybyastandard post mortem
procedure. The experiment was ended when
the mice were between 57 and 61 weeks old.
A full routine post mortem examination,
which included distension of the urinary
bladder with fixative, was carried out. Exa-
mination of the brain and spinal cord was
not undertaken. The number of lesions
thought to be neoplasms, and the sizes ofthe
largest of these in each organ affected, were
recorded.
All tissues with neoplasms or other lesions
were examined histologically. Tissues were
fixed in Bouin's solution and 5 pu paraffin wax
sections were prepared and stained with
haematoxylin and eosin.
RESULTS
The results are summarized in Tables I
and II.
Survival.-Between weaning and the
termination ofthe experiment, at 401-431
days, more mice in Groups A and D died,
or had to be killed because they were sick
or had large tumours, than in the other
groups. Post mortem examination was not
possible in 22 mice because of decomposi-
tion (Group A: 1 {, Group B: 1 3,
Group C: 1 Y, Group D: 11 3 and 5 Y and
Group E: 3y).
The data recorded in Table I and
in the following section of the text
refer only to mice that were examined
post mortem.
Sarcomata at the site of injection (see
Table I).-Eleven mice of Group A, 1 of
Group B and 2 of Group D developed
sarcomata at the site of subcutaneous
injection. Histologically all these tumours,
except 2 of those in Group A, were
fibrosarcomata. In one Group A female,
the tumour was a pleomorphic sarcoma
and in one male it was a rhabdomyo-
sarcoma.
Lung tumours (see Table II).-No
lung tumours were seen in 34 control
males (Group E) but one of 40 control
females developed a single small lung
tumour. One of 33 males and one of 38
females in Group C each developed a
solitary lung tumour. By contrast, a
high incidence oflung tumours was seen in
both the males and females of Groups A,
B and D. In terms of incidence of mice
with tumours, tumour multiplicity, and
average size of the largest tumour, the
response was slightly less marked in the
females of Group B than in those of
Groups A and D, whereas the response in
males was somewhat greater in Group D
than in Groups A and B.
The lung tumours ranged in histo-
logical appearance from non-invasive ade-
nomata (Grade 1) through locally invasive
adenocarcinomata (Grade 2) to adeno-
carcinomata showing metastases via the
airways to other parts ofthe lobe oforigin
(Grade 3) and adenocarcinomata showing
invasion of the chest wall (Grade 4). No
case of metastasis to extrathoracic sites
(Grade 5) was seen. The incidence of
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Grade 3 and Grade 4 lung tumours in the
5 groups was as follows:
Group A: 2 male and 3 female.
Group B: 0 male and 1 female.
Group C: 0 male and 1 female.
Group D: 2 male and 7 female.
Group E: 0 male and 0 female.
Liver tumours (see Table 11).-One of
34 control males (Group E) developed a
single liver tumour. Eight of 33 males of
Group C developed liver tumours and in
3 of these multiple nodules were seen. In
contrast, multiple liver tumours developed
in the majority of males in Groups A, B
and D. In terms of multiplicity of
tumours and average size of the largest
tumour, the response was similar in
Groups A, B and D.
In females, no liver tumours were seen
in the controls (Group E) nor in mice of
Group C, but a low incidence was en-
countered in Groups A, B and D.
Histologically, all the liver tumours
were derived from parenchymal cells.
They varied in appearance from being
difficult to distinguish from normal liver
in cellular size and arrangement to being
grossly abnormal in both these respects.
Some were of a papillary arrangement
and some showed evidence of local
invasiveness, but none had invaded ab-
dominal organs other than the liver and
no distant metastases were seen.
Malignant lymphoma. The only other
neoplasms seen in the experiment were 8
cases of malignant lymphoma: 3 in Group
A, 2 in Group B, 2 in Group D and 1 in
Group E (Table I). In 2 cases the thymus
was the organ principally involved (one
female of Group A and one female of
Group E). In all other instances there
was generalized involvement of lymphatic
tissues. Some of the tumours were of
stem cell type and some of lymphocytic
type.
Other pathological changes.-Foci of
round cell infiltration were seen in the wall
of the urinary bladder in a proportion of
mice of all groups. The incidence of
this change was not associated with
treatment. No significant changes were
observed in the bladder epithelium of any
mice.
No changes of obvious significance
were encountered in any other organ.
DISCUSSION
Marked differences in tumour incidence
were seen between the 4 groups. 7-
Methylbenz(a)anthracene (Group A) was
markedly more productive of sarcomata
at the site of injection than any of the
other compounds. 7-Methylbenz(a)anth-
racene (Group A), 7-bromomethylbenz-
(a)anthracene (Group B) and 7-bromo-
methyl - 12 - methylbenz(a)anthracene
(Group D) all evoked a high incidence of
lung tumours in both male and female
mice. 4-Chloro-7-bromomethylbenz(a)-
anthracene (Group C), on the other hand,
evoked no more lung tumours than did the
vehicle only (Group E).
The sex difference in liver tumour
incidence was not unexpected since male
mice are generally more susceptible to the
developmentofthesetumoursthanfemales
(Roe et al., 1971). However, it is of
interest that in the present experiment
livertumourstendedto arise preferentially
in the females of the groups in which the
males were most severely affected.
The incidence of lymphoma was too
low to provide an index of the relative
tumorigenicity of the 4 compounds. The
results with respect to the liver and lung
tumours suggest that the 4 compounds
can be ranked in the following descending
order of tumorigenicity in the newborn
mouse test system:
Most active
7-bromomethyl-12-methylbenz(a)-
anthracene (Group D)
7-methylbenz(a)anthracene (Group A)
Less active
7-bromomethylbenz(a)anthraceile
(Group B)
Least active
4-chloro-7-bromomethylbenz(a)-
anthracene (Group C)
This order is similar to that found by
464CARCINOGENIC ACTIVITY IN NEWBORN MICE 465
Dipple and Slade (1971) in their com-
parison of the same compounds in respect
of tumour-initiating activity for mouse
skin. In the present experiment, how-
ever, 7-bromomethylbenz(a)anthracene
exhibited more activity than expected
from the results ofthe earlier experiments
and was, in fact, only slightly less active
than the 12-methyl compound. The
difference between the results could be
due either to the fact that in the present
experiment much higher doses of all com-
pounds (on a per unit body weight basis)
were used, or that the tumour response in
the present experiment was manifest
mainly in the lungs and liver rather than
at the site of application of the agent.
The half-life ofthe 12-methyl derivative is
only one-tenth that of 7-bromomethyl-
benz(a)anthracene (Dipple and Slade,
1970) and, therefore, any time required
for the agent to be transported from the
site of injection to the target organ has
the effect of reducing the dose of 7-
bromomethyl-12-methylbenz(a)anthracene
relative to that of 7-bromomethylbenz(a)-
anthracene for that organ. However,
since so much work has been undertaken
on the assumption that 7-bromomethyl-
benz(a)anthracene is a carcinogen, it is an
important feature of the present results
that the effect of this compound on
tumour incidence was convincingly posi-
tive.
Interest in the comparative carcino-
genic activities of 7-methyl- and 7-
bromomethylbenz(a)anthracene stems
from postulated mechanisms of meta-
bolic activation of methyl-substituted
hydrocarbons which involve the methyl
group as the critical site of metabolic
attack (Boyland and Sims, 1965; Miller
and Miller, 1967; Dipple, Lawley and
Brookes, 1968; Flesher and Sydnor, 1971).
Since, in the present experiments, the
bromo-compound was less active overall
than the parent hydrocarbon, the data do
not support these theories. However,
carcinogenicity tests of reactive deriva-
tives do not constitute critical tests of
postulated mechanisms of metabolic acti-
vation. On the other hand, it is hoped
that the information already obtained
from carcinogenicity studies in various
whole animal systems, together with
information from studies now in progress
on the chemical reactivity of the same
compounds (Dipple et al., 1971), will
clarify the mechanism by which the
reactive derivatives themselves evoke the
carcinogenic response.
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